TLX 1.54% $20.44 telix pharmaceuticals limited

Understanding Telix, page-1163

  1. 90 Posts.
    lightbulb Created with Sketch. 15
    From Navartis quarterly:

    Pluvicto (USD 345 million, +44% cc) grew in the US and Europe. With supply now unconstrained, the focus is on increasing share in established RLT sites, opening new sites and referral pathways, and initiating new patients.

    USD$655 mill for the half.
 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.